At the news
? BULLISHIMPACT 5/10 8-K filed Jul 15, 2026 at 09:03 ET
GSK plc has completed its acquisition of Nuvalent, Inc. via a tender offer and merger. The tender offer expired with 91.3% of shares tendered, and the merger closed on July 15, 2026, at $124.00 per share in cash, representing a total equity value of approximately $10.6 billion. All outstanding shares, options, and RSUs were cashed out, and the company will be delisted from Nasdaq.
- Tender offer expired on July 14, 2026 with 72,518,967 shares (91.3% of outstanding) validly tendered
- Merger closed on July 15, 2026 under DGCL Section 251(h) without a stockholder vote
- Shareholders received $124.00 per share in cash, less applicable withholding
- Total equity value of the transaction approximately $10.6 billion
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access